Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 8,957 |
|
|||||
| News | - | ||||||
| Day High | 4.5001 | Low High |
|||||
| Day Low | 4.17 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Kineta Inc | KA | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -0.18 | -4.14% | 4.17 | 15:00:42 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 4.26 | 4.17 | 4.5001 | 4.17 | 4.35 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 159 | 8,957 | US$ 4.41 | US$ 39,500 | - | 1.7799 - 9.00 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 15:00:00 | 124 | US$ 4.39 | USD |
Kineta Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 19.64M | 10.39M | - | 1.95M | -63.41M | -6.10 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Kineta News
| Date | Time | Source | News Article |
|---|---|---|---|
| 11/30/2023 | 16:21 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 11/13/2023 | 16:28 | Edgar (US Regulatory) | Form 424B3 - Prospectus [Rule 424(b)(3)] |
| 11/06/2023 | 07:30 | Edgar (US Regulatory) | Form 8-K - Current report |
| 11/03/2023 | 15:25 | Edgar (US Regulatory) | Form S-3 - Registration statement under Securities Act of.. |
| 11/03/2023 | 15:04 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 11/03/2023 | 15:02 | Edgar (US Regulatory) | Form 8-K - Current report |
| 11/03/2023 | 15:01 | Edgar (US Regulatory) | Form 8-K - Current report |
| 10/20/2023 | 12:04 | Edgar (US Regulatory) | Form D - Notice of Exempt Offering of Securities |
| 10/17/2023 | 07:32 | Edgar (US Regulatory) | Form 8-K - Current report |
| 10/12/2023 | 15:25 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 10/05/2023 | 15:05 | Edgar (US Regulatory) | Form 8-K - Current report |
| 10/05/2023 | 09:47 | Edgar (US Regulatory) | Form 424B5 - Prospectus [Rule 424(b)(5)] |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical KA Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 3.43 | 4.77 | 3.43 | 4.15 | 17,720 | 0.74 | 21.57% |
| 1 Month | 4.18 | 4.77 | 2.99 | 3.67 | 14,462 | -0.01 | -0.24% |
| 3 Months | 2.11 | 5.39 | 1.93 | 3.41 | 30,908 | 2.06 | 97.63% |
| 6 Months | 3.04 | 5.39 | 1.7799 | 2.96 | 25,426 | 1.13 | 37.17% |
| 1 Year | 8.88 | 9.00 | 1.7799 | 3.96 | 27,694 | -4.71 | -53.04% |
| 3 Years | 8.88 | 9.00 | 1.7799 | 3.96 | 27,694 | -4.71 | -53.04% |
| 5 Years | 8.88 | 9.00 | 1.7799 | 3.96 | 27,694 | -4.71 | -53.04% |
Kineta Description
| Kineta Inc is a clinical-stage biotechnology company with a mission to develop next generation immunotherapies that transform patients' lives. The company's lead asset is KVA12.1, a VISTA blocking immunotherapy. |
